Table 1.

Sample Characteristics

	Group
	Healthy controls (n = 43)		Schizophrenia (n = 42)
Characteristic	M	SD	M	SD	p
Demographics
Age	41.30	14.57	42.74	14.88	.65
Gender (% male)	67.4%		73.8%		.42
Race (% non-Caucasian)	62.8%		52.4%		.94
Years education	15.58	1.95	13.64	2.44	<.001
Medication status
Typical AP (%)	n/a		7.1%		n/a
Atypical AP (%)	n/a		61.9%		n/a
Typical and atypical AP (%)	n/a		11.9%		n/a
Chlorpromazine equivalent	n/a		206.68	231.42	n/a
Clinical ratings
PANSS positive symptoms	n/a		15.31	6.01	n/a
PANSS negative symptoms	n/a		13.81	5.28	n/a
PANSS disorganized thought	n/a		10.88	3.40	n/a
Self-reports
EQ	45.98	9.97	38.37	12.02	.02
ECR—Global Avoidance	2.93	.94	2.69	1.28	.33
ECR—Global Anxiety	2.07	1.07	2.48	1.29	.12
Social cognitiona
TASIT—Lie (placebo)	.82	.10	.78	.13	.11
TASIT—Sarcasm (placebo)	.74	.17	.66	.19	.10
TASIT—Lie (oxytocin)	.82	.12	.77	.12	.11
TASIT—Sarcasm (oxytocin)	.77	.15	.70	.15	.09

Note. AP = antipsychotics; ECR = Experience in Close Relationships = Scale; EQ = Empathy Quotient; PANSS = Positive and Negative Syndrome Scale; TASIT = The Awareness of Social Inference Test.

^aSchizophrenia group, n = 28; healthy controls, n = 31.